Total Funding
33
69
Total FundingGrant raised
Growth Score 33 in past quarter
0 pts
Heat Score 69 in past quarter
2 pts
Company Performance Metrics
Score
Trend
AI Content may contain mistakes and is not legal, financial or investment advice.Learn more.
Growth Score - The measure of growth based on company activity, operational metrics, and investments
Growth Trend - The change in the growth score over the given time period
Heat Score - The measure of the market interest, media activity, and Crunchbase profile activity
Heat Trend - The change in the heat score over the given time period
Recent Milestones
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
Raised Funding Round
Jan 1, 1970
Lorem ipsum dolor sit amet, consectetur
See more interactive data and historical milestones on desktop for the best experience
163633
Neolys develops efficient solutions to help clinicians to adapt treatment to individual radiosensitivity of each patient: Precision Medicine
- Gilles Devillers: Co-Founder & President
- Nicolas Foray: Co-Founder
About the Company
Dedicated to bringing precision medicine in radiotherapy, Neolys Diagnostics, a Lyon (France) based company, develops innovative and efficient solutions to improve patients’ outcome and treatments,. It proposes efficient solutions for decision-making tool to radiation oncologists, allowing them to adapt treatment as per radiosensitivity of
individual patient. This helps in reducing side effects while optimizing the treatment efficiency.
